Top Markets
Coin of the day
IPROMOMED IPROMOMED

IPROMOMED

PRMD
Rank in Stocks #9277
Operating out of Russia, iPROMOMED functions as a pharmaceutical and... Operating out of Russia, iPROMOMED functions as a pharmaceutical and biotechnology enterprise dedicated to the research, production, and commercialization of both traditional prescription medications and cutting-edge therapeutic solutions.
Share Price
$4.93
Last synced: 2026-08-28
Market Cap
$1.05B
Change (1 day)
1.36%
Change (1 year)
-9.02%
Country
RU
Trade IPROMOMED (PRMD)

Category

Earnings for IPROMOMED (PRMD)
Earnings in 2026 TTM: 0
According to IPROMOMED latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for IPROMOMED from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors